1)Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46: 470-2
|
|
|
2)池田昭夫.発作のメカニズム.In: 三國信啓,他編.脳神経外科診療プラクティス3脳神経外科医のための脳機能と局在診断.東京: 文光堂; 2014.p.306-13
|
|
|
3)International Headache Society. The international classification of headache disorders: 3rd edition. Cephalalgia. 2013; 33: 721-2
|
|
|
4)慢性頭痛の診療ガイドライン作成委員会.片頭痛のcomorbid disorders(共存症)にはどのようなものがあるか.In: 慢性頭痛の診療ガイドライン2013.東京: 医学書院; 2013. p.105-6
|
|
|
5)Leniger T, Isbruch K, von den Driesch S, et al. Seizure-associated headache in epilepsy. Epilepsia. 2001; 42: 1176-9
|
|
|
6)Cianchetti C, Pruna D, Ledda M. Epileptic seizures and headache/migraine: a review of types of association and terminology. Seizure. 2013; 22: 679-85
|
|
|
7)Verrotti A, Coppola G, Spalice A, et al. Peri-ictal and inter-ictal headache in children and adolescents with idiopathic epilepsy: a multicenter cross-sectional study. Childs Nerv Syst. 2011; 27: 1419-23
|
|
|
8)Tsuji S. Migraine and epilepsy. Rinsho Shinkeigaku. 2014; 54: 1003-5
|
|
|
9)Ikeda A, Kakigi R, Funai N, et al. Cortical tremor: a variant of cortical reflex myoclonus. Neurology. 1990; 40: 1561-5
|
|
|
10)Yasuda T. Benign adult familial myoclonic epilepsy (BAFME). Kawasaki Med J. 1991; 17: 1-13
|
|
|
11)Terada K, Ikeda A, Mima T, et al. Familial cortical myoclonic tremor as a unique form of cortical reflex myoclonus. Mov Disord. 1997; 12: 370-7
|
|
|
12)Guerrini R, Bonanni P, Patrignani A, et al. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2. Brain. 2001; 124: 2459-75
|
|
|
13)van Rootselaar AF, van Schaik IN, van den Maagdenberg AM, et al. Familial cortical myoclonic tremor with epilepsy: a single syndromic classification for a group of pedigrees bearing common features. Mov Disord. 2005; 20: 665-73
|
|
|
14)Uyama E, Fu YH, Ptácek LJ. Familial adult myoclonic epilepsy (FAME). Adv Neurol. 2005; 95: 281-8
|
|
|
15)Mikami M, Yasuda T, Terao A, et al. Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1. Am J Hum Genet. 1999; 65: 745-51
|
|
|
16)Striano P, Chifari R, Striano S, et al. A new benign adult familial myoclonic epilepsy (BAFME) pedigree suggesting linkage to chromosome 2p11.1-q12.2. Epilepsia. 2004; 45: 190-2
|
|
|
17)Hitomi T, Takahashi R, Ikeda A. Recent advance in research of benign adult familial myoclonus epilepsy (BAFME): is BAFME a progressive disorder? Rinsho Shinkeigaku. 2014; 54: 1142-5
|
|
|
18)Hitomi T, Ikeda A, Kondo T, et al. Increased cortical hyperexcitability and exaggerated myoclonus with aging in benign adult familial myoclonus epilepsy. Mov Disord. 2011; 26: 1509-14
|
|
|
19)Coppola A, Santulli L, Del Gaudio L, et al. Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy. Epilepsia. 2011; 52: 1245-50
|
|
|
20)Ikeda A, Kurihara S, Shibasaki H. Possible anticipation in BAFME: three generations examined in a Japanese family. Mov Disord. 2005; 20: 1076-7
|
|
|
21)Hitomi T, Kondo T, Kobayashi K, et al. Clinical anticipation in Japanese families of benign adult familial myoclonus epilepsy. Epilepsia. 2012; 53: e33-6
|
|
|
22)Hitomi T, Kobayashi K, Jingami N, et al. Increased clinical anticipation with maternal transmission in benign adult familial myoclonus epilepsy in Japan. Epileptic Disord. 2013; 15: 428-32
|
|
|
23)高橋 均.BAFMEの神経病理.第30回日本臨床神経生理学会学術大会シンポジウム2 BAFME (Benign Adult Familial Myoclonic Epilepsy). 2001; 29: 87
|
|
|
24)Tijssen MA, Thom M, Ellison DW, et al. Cortical myoclonus and cerebellar pathology. Neurology. 2000; 54: 1350-6
|
|
|
25)Striano P, Caranci F, Di Benedetto R, et al. (1)H-MR spectroscopy indicates prominent cerebellar dysfunction in benign adult familial myoclonic epilepsy. Epilepsia. 2009; 50: 1491-7
|
|
|
26)Long L, Song Y, Zhang L, et al. A case-control proton magnetic resonance spectroscopy study confirms cerebellar dysfunction in benign adult familial myoclonic epilepsy. Neuropsychiatr Dis Treat. 2015; 11: 485-91
|
|
|
27)van Rootselaar AF, Maurits NM, Renken R, et al. Simultaneous EMG-functional MRI recordings can directly relate hyperkinetic movements to brain activity. Hum Brain Mapp. 2008; 29: 1430-41
|
|
|
28)Buijink AW, Caan MW, Tijssen MA, et al. Decreased cerebellar fiber density in cortical myoclonus tremor but not in essential tremor. Cerebellum. 2013; 12: 199-204
|
|
|
29)Wang P, Luo C, Dong L, et al. Altered intrinsic brain activity in patients with familial cortical myoclonic tremor and epilepsy: an amplitude of low-frequency fluctuation study. J Neurol Sci. 2015; 351: 133-9
|
|
|
30)Toyota T, Akamatsu N, Tanaka A, et al. Electroencephalographic features of benign adult familial myoclonic epilepsy. Clin Neurophysiol. 2014; 125: 250-4
|
|
|
31)Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist. 2007; 13: 261-71
|
|
|
32)Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011; 69: 303-11
|
|
|
33)Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007; 61: 25-36
|
|
|
34)Ikeda A, Matsui M, Hase Y, et al. “Burst and slow complexes” in nonconvulsive epileptic status. Epileptic Disord. 2006; 8: 61-4
|
|
|
35)Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012; 79: 1094-100
|
|
|
36)Dericioglu N, Vural A, Acar P, et al. Antiepileptic treatment for anti-NMDA receptor encephalitis: the need for video-EEG monitoring. Epileptic Disord. 2013; 15: 166-70
|
|
|
37)Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12: 157-65
|
|
|
38)Dalmau J, Lancaster E, Martinez-Hernandez E, et el. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10: 63-74
|
|
|
39)Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013; 70: 271-8
|
|
|
40)Liba Z, Sebronova V, Komarek V, et al. Prevalence and treatment of anti-NMDA receptor encephalitis. Lancet Neurol. 2013; 12: 424-5
|
|
|
41)Finke C, Kopp UA, Prüss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012; 83: 195-8
|
|
|
42)日本精神神経学会,監修.DSM-5精神疾患の診断・統計マニュアル.東京: 医学書院; 2014
|
|
|
43)Iseki K, Ikeda A, Kihara T, et al. Impairment of the cortical GABAergic inhibitory system in catatonic stupor: a case report with neuroimaging. Epileptic Disord. 2009; 11: 126-31
|
|
|
44)Primavera A, Fonti A, Novello P, et al. Epileptic seizures in patients with acute catatonic syndrome. J Neurol Neurosurg Psychiatry. 1994; 57: 1419-22
|
|
|
45)Sahaya K, Lardizabal D. Catatonia in encephalitis and nonconvulsive seizures: a case report and review of the literature. Epilepsy Behav. 2010; 17: 420-5
|
|
|
46)鈴木一正,訳.カタトニアー臨床医のための診断・治療ガイドライン.東京: 星和書店; 2007
|
|
|
47)櫻井健世,人見健世,池田昭夫.カタトニーは不随意運動か? 「No」の立場から.Frontiers in Parkinson Disease. 2015; 8: 18-20
|
|
|
48)Kiani R, Lawden M, Eames P, et al. Anti-NMDA-receptor encephalitis presenting with catatonia and neuroleptic malignant syndrome in patients with intellectual disability and autism. BJPsych Bull. 2015; 39: 32-5
|
|
|
49)Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol. 2012; 27: 1460-9
|
|
|